UChicago Medicine Comprehensive Cancer Center

UChicago Medicine offers state-of-the-art, minimally invasive focal therapy treatments designed to target prostate cancer while preserving healthy tissue. Our team of specialists is dedicated to providing innovative therapies such as high-intensity focused ultrasound (HIFU), cryoablation, irreversible electroporation (IRE), and TULSA Pro to ensure the best possible outcomes for patients.

Patient Education

Hear Dr. Sidana's library of talks explaining focal therapy treatments in detail here.

High-Intensity Focused Ultrasound (HIFU)

High-intensity focused ultrasound (HIFU) is a non-invasive treatment that uses focused ultrasound waves to heat and destroy cancer cells. HIFU precisely targets cancerous tissue without harming the surrounding healthy tissue.

Irreversible Electroporation (IRE)

Irreversible electroporation (IRE), also known as NanoKnife, is a cutting-edge treatment that uses electrical pulses to destroy cancer cells. This technique spares surrounding healthy tissues, making it an excellent option for prostate cancer in sensitive areas.

Cryoablation

Cryoablation is a minimally invasive treatment that uses extremely cold temperatures to freeze and destroy cancer cells. This technique has been proven safe and effective for localized prostate cancer.

TULSA Pro

TULSA Pro, or Transurethral Ultrasound Ablation, combines real-time MRI imaging with precise ultrasound energy to treat prostate cancer. This advanced treatment provides exceptional accuracy and personalization.

Clinical Trials and Research at UChicago

The University of Chicago is a leader in advancing prostate cancer treatment through innovative clinical trials and leading-edge research in focal therapy. Our team is dedicated to improving the precision, safety, and effectiveness of treatments, ensuring that patients have access to the latest advancements in care.

Request an Appointment for Prostate Cancer Care

We are currently experiencing a high volume of inquiries, leading to delayed response times. For faster assistance, please call 1-855-702-8222 to schedule your appointment.

If you have symptoms of an urgent nature, please call your doctor or go to the emergency room immediately.

For Referring Physicians

To refer a patient for prostate cancer care, please call UCM Physician Connect at 1-800-824-2282

By submitting this form you acknowledge the risk of sending this information by email and agree not to hold the University of Chicago or University of Chicago Medical Center liable for any damages you may incur as a result of the transfer or use of this information. The use or transmittal of this form does not create a physician-contact relationship. More information regarding the confidentiality of this request can be found in our Privacy Policy.

* Indicates required field

By submitting this form you acknowledge the risk of sending this information by email and agree not to hold the University of Chicago or University of Chicago Medical Center liable for any damages you may incur as a result of the transfer or use of this information. The use or transmittal of this form does not create a physician-contact relationship. More information regarding the confidentiality of this request can be found in our Privacy Policy.
Randy Sweis, MD, medical oncologist

Cancer Care Second Opinions

Request a second opinion with a UChicago Medicine urologic cancer expert.

genetic testing illustration

High Risk & Advanced Prostate Cancer Clinic

Focused care for men at risk for prostate cancer and those with advanced disease.

researcher in cancer lab

Participate in a Prostate Cancer Clinical Trial

UChicago Medicine physician-scientists are actively conducting clinical trials of new therapies for prostate cancer.